Target intelligence / Profile preview

DNA strand

Molecular classification
Other (Nucleic acid polymer)
01

Overview

A DNA strand, also called a polynucleotide chain, is a linear polymer composed of nucleotide monomers. Each nucleotide consists of a deoxyribose sugar, phosphate group, and one of four nitrogenous bases—adenine (A), cytosine (C), guanine (G), and thymine (T). The backbone is formed by alternating sugar and phosphate groups linked via phosphodiester bonds. Each strand has directionality defined by its chemical ends—5′ phosphate and 3′ hydroxyl. In cells, two complementary antiparallel strands form the iconic double helix structure stabilized by hydrogen bonding between paired bases. The sequence encodes genetic information essential for heredity and cellular function; it serves as both template for its own replication during cell division and for RNA synthesis during gene expression.

Other names
Deoxyribonucleic acid strandPolynucleotide chainDNA chain
02

Mechanism of action

Intercalation between base pairs causing disruption of replication/transcription (e.g., doxorubicin); Alkylation/crosslinking of bases leading to strand breaks or mispairing (e.g., cisplatin, cyclophosphamide); Induction of single/double-strand breaks by free radicals or direct cleavage (e.g., bleomycin)

03

Biological functions

Genetic information storageTemplate for replicationTemplate for transcription (gene expression)Heredity and inheritance
04

Disease associations

Cancer (mutations in DNA strands can lead to cancer)Genetic disorders (mutations or structural abnormalities in DNA strands cause inherited diseases)Infection (some pathogens target or integrate into host DNA)
05

Safety considerations

Off-target toxicity due to non-specific damage to normal cell DNA by chemotherapeuticsMyelosuppressionSecondary malignanciesInfertility
06

Interacting drugs

Cisplatin

4 more in the full profile.

07

Biomarkers

Mutational signatures in specific genes/sequences within the genome are used as biomarkers but not the generic "DNA strand"BRCA1/2 mutationsTP53 mutations

Beyond the preview

Go deeper on DNA strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call